Autoimmune Diseases Market

1
Autoimmune Diseases Market Trends, Size, Share,
Demands, Overview, Growth, Revenue and Forecast
to 2028
sales_at_delvens.com www.delvens.com
2
Sternal Closure Systems Market Trends Forecast
Till 2030
Autoimmune Diseases Market is segmented by Drug
Class (Anti-Inflammatory, Antihyperglycemics,
NSAIDs, Interferons, and Others), Indication
(Rheumatic Disease, Type 1 Diabetes, Multiple
Sclerosis, , Inflammatory Bowel Disease and
Others) and Sales Channel (Hospital Pharmacy,
Drug Store Retail Pharmacy, and Online Store),
and region (North America, Europe, Asia-Pacific,
Middle East and Africa and South
America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/autoimmune
-diseases-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
An autoimmune disease causes the immune system to
destroy its own body tissue. There are more than
80 different types of autoimmune disorders
however, lupus, multiple sclerosis, IBS, type 1
diabetes, rheumatoid arthritis, psoriasis, and
others are the most common form of autoimmune
disease. Different types of drugs such as
anti-inflammatory, NSAIDs, interferons, immune
suppressants, corticosteroids, and others, are
approved for the treatment of autoimmune
disease. Increase in incidence of autoimmune
disease, surge in adoption of autoimmune disease
therapeutics, and growth in RD activities to
develop ideal therapeutics are some of the
factors that have supported long-term expansion
for Autoimmune Diseases Market. Purchase this
Report https//www.delvens.com/checkout/autoimmun
e-diseases-market
sales_at_delvens.com
www.delvens.com
4
Key Findings
The Autoimmune Diseases Market is segmented into
various segments such as sales channel,
indication, drug class type and region On the
basis of Sales Channel Hospital Pharmacy Drug
Store Retail Pharmacy Online Store              
                                  On the basis
of Indication Rheumatic Disease Type 1
Diabetes Multiple Sclerosis Inflammatory Bowel
Disease Other Indications
sales_at_delvens.com
www.delvens.com
5
Key Findings
The market is also divided into various regions
such as North America, Europe, Asia-Pacific,
South America, and Middle East and Africa. North
America is estimated to account for the largest
market share during the forecast period. Inquire
Before Buying https//www.delvens.com/Inquire-bef
ore-buying/autoimmune-diseases-market
sales_at_delvens.com
www.delvens.com
6
Competitive Landscape

• AstraZeneca plc.
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche AG
• Johnson Johnson
• Novartis AG
• Pfizer Inc.
• UCB S.A

sales_at_delvens.com
www.delvens.com
7
Recent Developments
In July 2017, AARDA, in partnership with the
Relapsing Polychondritis Awareness Support
Foundation (RPASF), hosted the first Bowling
Green Autoimmune Walk and Warriors 5K Fun Run to
raise awareness and funding for innovative
research. In May 2017, Thermo Fisher Scientific
acquired Patheon. In June 2017, Bio-Rad signed
an agreement with VISIA imaging for
fully-automated IFA Slide Processing and Reading
System. Thus, the market has been witnessing
technological developments on a large scale for
the past couple of years.
sales_at_delvens.com
www.delvens.com
8
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com